Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

4.84
Delayed Data
As of Sep 23
 -0.10 / -2.02%
Today’s Change
1.61
Today|||52-Week Range
13.97
+109.52%
Year-to-Date
5 Biotech Stocks That Are Broker Favorites
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.94
Today’s open4.92
Day’s range4.81 - 4.95
Volume114,084
Average volume (3 months)262,775
Market cap$199.4M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-17.31%
Earnings growth (this year)+59.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-73.74%
P/E ratioNM
Price/Sales91.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.18-2.40%
IMDZImmune Design Corp-0.17-2.09%
EGLTEgalet Corp+0.14+1.80%
STMLStemline Therapeutic...+0.35+3.42%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$518.3K
Annual profit (last year)-$74.8M
Net profit margin-14,428.77%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Financial Officer &
Vice President
Richard D. Katz
Corporate headquarters
Durham, North Carolina

Forecasts

Search for Jobs